MIMETAS, a leader in human 3D disease modeling, and Yamaha Motor Co., Ltd., a developer of the CELL HANDLER™, announce a strategic joint marketing agreement aimed at advancing therapeutic development using human-relevant models throughout the early drug development pipeline. The collaboration combines MIMETAS’ comprehensive disease modeling and assay development expertise with Yamaha Motor's state-of-the-art CELL HANDLER, an automated system for selecting, picking and imaging spheroids, tissues and organoids.
MIMETAS and Yamaha Motor will work together to develop innovative applications of the CELL HANDLER in combination with MIMETAS’ 3D tissue models. The result is an end-to-end solution, providing pharmaceutical researchers with essential tools to expedite their drug discovery endeavors. The integrated solution will allow automated integration of organoids, spheroids, and tumors tissues into vascularized, perfused and immunocompetent tissues, with increased throughput and improved robustness and reproducibility.
For more information about this collaboration and to stay updated on the latest developments, please visit: www.mimetas.com and https://global.yamaha-motor.com/cn/business/hc/.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!